Good gift to "rabbit" you, "cell" you are satisfied!
2023-02-27
New Year's Day | Wuhan sample library is recognized as a high-tech enterprise
- Categories:Enterprise News
- Author:
- Origin:
- Time of issue:2023-01-13 17:26
- Views:
(Summary description)According to the relevant provisions of the Administrative Measures for the Identification of High-tech Enterprises (GKFH [2016] No. 32) and the Guidelines for the Identification and Management of High-tech Enterprises (GKFH [2016] No. 195), the National Leading Community Office for the Identification and Management of High-tech Enterprises issued the "Notice on the Filing and Publicity of the Fifth Batch of High-tech Enterprises Identified by the Hubei Provincial Accreditation Agency in 2022", Wuhan Biological Sample Bank Co., Ltd. (hereinafter referred to as "Wuhan Sample Bank") is recognized as a high-tech enterprise. High-tech enterprises refer to resident enterprises that have been registered in China (excluding Hong Kong, Macao and Taiwan) for more than one year by continuously carrying out research and development and transformation of technological achievements, forming core independent intellectual property rights of enterprises, and carrying out business activities on this basis within the "High-tech Fields Supported by the State". It is a knowledge-intensive and technology-intensive economic entity. In the future, Wuhan sample bank will further promote the conservation and utilization of human genetic resources and the transformation of achievements, and promote the innovation of biotechnology sources, so that Wuhan sample bank will become a "national" brand platform with strong "hematopoietic" ability, and help the high-quality development of the big health industry.
New Year's Day | Wuhan sample library is recognized as a high-tech enterprise
(Summary description)According to the relevant provisions of the Administrative Measures for the Identification of High-tech Enterprises (GKFH [2016] No. 32) and the Guidelines for the Identification and Management of High-tech Enterprises (GKFH [2016] No. 195), the National Leading Community Office for the Identification and Management of High-tech Enterprises issued the "Notice on the Filing and Publicity of the Fifth Batch of High-tech Enterprises Identified by the Hubei Provincial Accreditation Agency in 2022", Wuhan Biological Sample Bank Co., Ltd. (hereinafter referred to as "Wuhan Sample Bank") is recognized as a high-tech enterprise.
High-tech enterprises refer to resident enterprises that have been registered in China (excluding Hong Kong, Macao and Taiwan) for more than one year by continuously carrying out research and development and transformation of technological achievements, forming core independent intellectual property rights of enterprises, and carrying out business activities on this basis within the "High-tech Fields Supported by the State". It is a knowledge-intensive and technology-intensive economic entity.
In the future, Wuhan sample bank will further promote the conservation and utilization of human genetic resources and the transformation of achievements, and promote the innovation of biotechnology sources, so that Wuhan sample bank will become a "national" brand platform with strong "hematopoietic" ability, and help the high-quality development of the big health industry.
- Categories:Enterprise News
- Author:
- Origin:
- Time of issue:2023-01-13 17:26
- Views:
According to the relevant provisions of the Administrative Measures for the Identification of High-tech Enterprises (GKFH [2016] No. 32) and the Guidelines for the Identification and Management of High-tech Enterprises (GKFH [2016] No. 195), the National Leading Community Office for the Identification and Management of High-tech Enterprises issued the "Notice on the Filing and Publicity of the Fifth Batch of High-tech Enterprises Identified by the Hubei Provincial Accreditation Agency in 2022", Wuhan Biological Sample Bank Co., Ltd. (hereinafter referred to as "Wuhan Sample Bank") is recognized as a high-tech enterprise.
High-tech enterprises refer to resident enterprises that have been registered in China (excluding Hong Kong, Macao and Taiwan) for more than one year by continuously carrying out research and development and transformation of technological achievements, forming core independent intellectual property rights of enterprises, and carrying out business activities on this basis within the "High-tech Fields Supported by the State". It is a knowledge-intensive and technology-intensive economic entity.
In the future, Wuhan sample bank will further promote the conservation and utilization of human genetic resources and the transformation of achievements, and promote the innovation of biotechnology sources, so that Wuhan sample bank will become a "national" brand platform with strong "hematopoietic" ability, and help the high-quality development of the big health industry.
